Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuying Xie
Yuying Xie
Hoffmann-La Roche
Internal medicine
Medicine
Gastroenterology
Diffuse large B-cell lymphoma
Correctness
4
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MOSUNETUZUMAB MONOTHERAPY IN ELDERLY/UNFIT PTS WITH FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): SAFETY AND EFFICACY REMAIN PROMISING WITH DURABLE COMPLETE RESPONSES
2021
Hematological Oncology
Adam J. Olszewski
Abraham Avigdor
S. Babu
Itai Levi
Herbert Eradat
Uri Abadi
Houston Holmes
Matthew S. McKinney
Dariusz Woszczyk
Krzysztof Giannopoulos
Wojciech Jurczak
Ronald McCord
Yuying Xie
Kati Sarouei
Naseer Qayum
Carol OHear
Gila Sellam
Netanel A. Horowitz
Show All
Source
Cite
Save
Citations (0)
ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses
2021
Clinical Lymphoma, Myeloma & Leukemia
Adam J. Olszewski
Abraham Avigdor
Sunil Babu
Itai Levi
Herbert Eradat
Uri Abadi
Houston Holmes
Matthew S. McKinney
Dariusz Woszczyk
Krzysztof Giannopoulos
Wojciech Jurczak
Ron McCord
Yuying Xie
Mingzhu Zhou
Naseer Qayum
Carol OHear
Gila Sellam
Netanel A. Horowitz
Show All
Source
Cite
Save
Citations (0)
Multiply robust estimation of causal quantile treatment effects.
2020
Statistics in Medicine
Yuying Xie
Cecilia A. Cotton
Yeying Zhu
Show All
Source
Cite
Save
Citations (1)
Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
2020
Blood
Adam J. Olszewski
Abraham Avigdor
Sunil Babu
Itai Levi
Uri Abadi
Houston Holmes
Matthew S. McKinney
Ron McCord
Yuying Xie
Cindy Chen
Kati Sarouei
Naseer Qayum
Carol OHear
Gila Sellam
Herbert Eradat
Show All
Source
Cite
Save
Citations (18)
1